2-Cyanothiazole

2-Cyanothiazole


    • Product Name 2-Cyanothiazole
    • Alias 2-isothiazolecarbonitrile
    • Einecs 674-515-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    791769

    Chemical Formula C3H2N2S
    Molar Mass 98.13 g/mol
    Appearance Solid
    Melting Point 90 - 92 °C
    Boiling Point 234 - 235 °C
    Solubility In Water Insoluble
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, acetone
    Density 1.38 g/cm³
    Pka N/A
    Flash Point 101 °C
    Odor Characteristic odor

    As an accredited 2-Cyanothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 2 - Cyanothiazole packaged in 1 - kg bottles for easy handling and storage.
    Shipping 2 - Cyanothiazole is shipped in sealed, corrosion - resistant containers. Adequate cushioning is used to prevent breakage. Shipments follow strict chemical transportation regulations to ensure safety during transit.
    Storage 2 - Cyanothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from sources of heat, ignition, and incompatible substances like strong oxidizing agents. Store in a tightly closed container to prevent moisture absorption and potential leakage. Ensure storage areas are out of reach of unauthorized personnel.
    Application of 2-Cyanothiazole

    In the manufacturing train for thiamethoxam and clothianidin, 2-cyanothiazole enters a chlorination cascade where the thiazole ring is functionalized before cyano-group reduction. This processing window demands precise stoichiometric control: the feedstock is charged into a glass-lined reactor with acetic acid as solvent, and N-chlorosuccinimide is metered at a molar ratio of 1.00:1.08–1.15 relative to the cyano substrate. Excess chlorinating agent is quenched with aqueous sodium metabisulfite when residual 2-cyanothiazole drops below 0.3% (by HPLC area). Reaction exotherms are managed by jacket brine held at −5 to 5°C, as runaway chlorination above 65°C yields ring-degradation impurities that contaminate downstream neonicotinoid crystallisation. Isolation proceeds through solvent swap, vacuum fractional distillation (boiling range 98–102°C at 8 mbar), and subsequent catalytic hydrogenation employing Raney-cobalt or modified Pd/C under 12–16 bar H₂ in methanolic ammonia to generate the 5-aminomethyl intermediate that feeds directly into the heterocyclic coupling sequence. Industry compliance for the resultant technical-grade active is governed by FAO Specification 375/TC (thiamethoxam), EPA 40 CFR 180.642 tolerance levels, and residue definitions under EU Reg. 396/2005; working concentrations are verified against CIPAC Handbook M methods. Downstream formulation yields finished products typified by thiamethoxam 25% WG, 70% WS, and 480 g/L FS, as well as clothianidin 50% WDG and 600 g/L FS. A critical processing boundary is the avoidance of strong aqueous bases during chlorinated intermediate storage, which triggers ring-opening hydrolysis and total potency loss.

    The conversion of 2-cyanothiazole into thiazole-2-carboxylic acid via alkaline hydrolysis presents a lower-genotoxicity alternative to the classic diazotization of 2-aminothiazole; this route avoids handling nitrosatable amine precursors during thiazole carboxamide fungicide synthesis. In a dedicated campaign, 2-cyanothiazole is refluxed in 20% (w/w) NaOH at 102–104°C for 6–8 h until ammonia evolution ceases; the resulting sodium carboxylate is acidified with hydrochloric acid to precipitate the free acid, which is dried to <0.1% moisture by azeotropic toluene distillation. Subsequent activation with thionyl chloride at a molar ratio of acid to SOCl₂ of 1:1.3–1.5 (with 0.5% v/v DMF as catalyst) in toluene at 65–70°C yields thiazole-2-carbonyl chloride. This intermediate is coupled under anhydrous conditions with 2,6-dibromo-4-(trifluoromethoxy)aniline (1.0 molar equivalent) in the presence of a tertiary amine scavenger. The entire acylation sequence demands reactor moisture specification below 50 ppm H₂O to prevent acyl chloride decomposition. Regulatory oversight for thifluzamide technical material adheres to FAO Specification 484/TC, EPA 40 CFR 180 data requirements, and its primary degradation pathway under OECD 302B inherent biodegradability test. Formulated end-uses primarily consist of thifluzamide 24% SC and 240 g/L SC targeting rice sheath blight, with application restrictions that exclude tank-mixing with strongly acidic adjuvants to avoid flocculation.

    Representative compliance standards intersecting neonicotinoid and carboxamide intermediate production
    StandardDisciplineRelevant substanceTest/Requirement
    FAO 375/TCSpecificationThiamethoxam technicalMinimum purity, water, insolubles
    FAO 484/TCSpecificationThifluzamide technicalActive content, suspension stability
    CIPAC Handbook MAnalyticalThiamethoxam formulationsHPLC/GC method validation
    EPA 40 CFR 180.642Residue toleranceThiamethoxamMRL in/on grains and oilseeds
    EU Reg. 1107/2009Placing on marketActive substancesAnnex II/III dossier completeness
    OECD 302BFateThifluzamideInherent biodegradability
    REACH Annex XVIIRestrictionCMR co-formulantsEntry 28–30 exclusion

    How Does a Cyano-Substituted Thiazole Enable Low-Nitrosamine Risk Febuxostat Routes?

    When retrosynthetic analysis of febuxostat—a xanthine oxidase inhibitor—identifies a 4-methyl-5-thiazolecarboxylic acid core, 2-cyanothiazole serves as a pre-functionalized building block that sidesteps the earlier manufacturing process reliant on carbon disulfide and secondary amines, thus minimising the potential for nitrosamine carryover into the API. In a representative batch protocol, 2-cyanothiazole is combined with 3-cyano-4-isobutoxyacetophenone at a molar excess of 3–8% (typical ratio 1.05:1.00) in acetonitrile containing ammonium acetate (2.5 molar equivalents). The mixture is heated to 75–80°C under reflux for 10–14 hours until the ketone intermediate is consumed below 0.5% (HPLC). Direct crystallisation by controlled water addition at 5–10°C isolates the crude thiazole ester precursor, which is then hydrolysed and recrystallised from ethanol/water to meet USP <1088.10> residual solvent limits (acetonitrile <410 ppm, ethanol <5000 ppm). Good manufacturing practice compliance follows ICH Q7 Active Pharmaceutical Ingredient guidelines, with narrow acceptance criteria for nitrosamine impurities as per EMA/408168/2022 and EP 10.0 general chapters. The resulting febuxostat is formulated into immediate-release oral tablets of 40 mg and 80 mg finished dosage strengths. A key operational boundary applies to the final hydrolysis step: exposure to prolonged heating above 85°C at alkaline pH promotes decarboxylation and the formation of the des-carboxy analogue, requiring tight pH-stat control.

    Within the supply chain of HIV-1 protease inhibitors, the conversion of 2-cyanothiazole to 2-aminomethylthiazole establishes the chiral side-chain scaffold required for ritonavir. Catalytic hydrogenation is performed in a Hastelloy C-276 autoclave charged with 6–8 wt% Raney-Ni 2800 slurry (relative to cyanothiazole mass) and 7 N methanolic ammonia. The vessel is pressurized with hydrogen to 12–14 bar and maintained at 45–50°C for 5–7 hours until the CN stretching band at 2230 cm⁻¹ disappears in the inline IR monitor. After catalyst filtration under inert gas and acidification with dry HCl gas, the amine hydrochloride precipitates and is recrystallised from isopropanol to achieve a purity exceeding 99.5%. This intermediate is then condensed with a (S)-3-chloro-1,2-propanediol acetonide or its activated derivative in a nucleophilic substitution to install the stereocenter. Quality gateways align with ICH Q3C(R8) residual solvent classes (methanol <3000 ppm, isopropanol <5000 ppm) and USP <467>. The regulatory standard for starting materials requires a nitrosamine risk assessment dossier under EMA/CHMP/CVMP/20531/2022. Finished drug products incorporating this chiral chain include ritonavir 100 mg film-coated tablets and 100 mg soft gelatin capsules. A notable scale-up fragility is the exothermicity of Raney-Ni additions to ammonia solutions; catalyst must be slurried under a nitrogen blanket and injected slowly to prevent foam-over and hot-spot formation.

    If Electrolyte Oxidation Stability at High Voltage Demands a Cyano-Functional SEI Former

    Lithium-ion cells designed for 4.4 V to 4.5 V upper cutoff potentials often incorporate 2-cyanothiazole as a functional electrolyte additive that undergoes preferential oxidative polymerization on the NMC cathode surface, forming a cyano-containing cathode electrolyte interphase (CEI) with reduced charge-transfer resistance growth. Blending protocols introduce the additive at a concentration of 0.8–2.5 wt% into a base electrolyte of 1.0 M LiPF₆ in EC:EMC:DMC (30:50:20 v/v). Following a 30-minute stirring and molecular sieve drying cycle to maintain moisture below 8 ppm, the electrolyte is injected into 18650 or 21700 cylindrical jelly rolls inside a dry room with a dew point of −45°C or lower. Formation cycling at 0.1C over 3 cycles builds a stable interphase; residual additive is consumed during the first charge plateau evidenced by a minor capacity offset of 1.5–2.8 mAh/g. Compliance documentation for commercial power cells must satisfy IEC 62660-3 mechanical and electrical safety parameters, UL 1642 lithium battery standard, UN 38.3 transport testing, and 2011/65/EU (RoHS) substance restrictions. End-use configurations encompass NMC811/graphite 4.5 Ah 21700 cells for power tools, drone propulsion packs, and LFP/graphite pouch cells where cyano-additive synergy with fluoroethylene carbonate extends calendar life. A firm processing limit exists: dosage above 3.0 wt% results in excessive polymerized CEI thickness and an abrupt rise in DC internal resistance by 40–60% after 100 cycles at 45°C, requiring strict gravimetric metering in the electrolyte batching unit.

    Effect of 2-cyanothiazole concentration on NMC811/graphite 21700 cell performance (45°C, 1C/1C cycle, 4.4 V cutoff)
    Additive loading (wt%)Formation capacity offset (mAh/g)DC resistance rise at 100 cycles (%)Capacity retention at 200 cycles (%)
    0.00.065–7278–82
    0.81.5–1.928–3486–90
    1.52.0–2.515–2291–94
    2.52.6–2.825–3387–91
    3.03.1–3.548–6079–84

    Synthesizing 2-Aminothiazole Motifs for Veterinary Anthelmintic Active Ingredients

    Nitazoxanide and structurally related anti-protozoal agents rely on a 2-amino-5-nitrothiazole core, which is built from 2-cyanothiazole through sequential nitration and cyano-group hydrolysis/reduction steps. The nitration protocol in a kilogram-scale pilot plant involves dropwise addition of 2-cyanothiazole into mixed acid composed of 98% sulfuric acid and 68% nitric acid at a volumetric ratio of 3:1, with the substrate-to-acid ratio maintained at 1 g per 8–10 mL of mixed acid. The temperature band is strictly clamped between −5 and 0°C; excursions above +2°C trigger rapid dinitration and the formation of genotoxic 2-cyano-3,5-dinitrothiazole. After 2–3 hours of post-addition stirring, the reaction mass is drowned onto crushed ice, and the precipitated 2-cyano-5-nitrothiazole is filtered, washed, and reduced directly with iron powder in acetic acid/water at 55–60°C to yield 2-amino-5-nitrothiazole. Acylation with acetylsalicyloyl chloride in dimethylacetamide at 10–15°C completes the API backbone. Veterinary drug regulatory compliance includes VICH GL18(R) (impurities in new veterinary drug substances), EU 37/2010 maximum residue limits in food-producing species, and residual solvent monitoring per USP <467>. Finished dosage forms target companion and livestock use: nitazoxanide 500 mg tablets and 100 mg/5 mL oral suspensions. A critical safety boundary is the energetic decomposition of isolated dry 2-cyano-5-nitrothiazole when exposed to impact or friction; therefore, the wet cake must be processed directly and never dried to LOD below 20% moisture before the reduction stage.

    Free Quote

    Competitive 2-Cyanothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The heterocyclic building block 2-cyanothiazole (CAS 1452-15-6, molecular formula C₄H₂N₂S, molecular weight 110.14 g mol⁻¹) is supplied as a pale yellow to amber crystalline solid with a melting point of 36–38 °C (ASTM E324-16) and a boiling point of 190–192 °C at atmospheric pressure. Commercial grades typically target a purity of ≥ 98.0% (HPLC, 254 nm, area%), with the primary impurity being 2-thiazolecarboxamide (≤ 1.5%) from incomplete dehydration of the precursor oxime. Moisture content, determined by Karl Fischer titration (ASTM E203-16), is routinely controlled to ≤ 0.5 wt%, as residual water accelerates hydrolysis of the nitrile function to the amide during storage. The product is packaged under dry nitrogen in fluorinated HDPE drums with polytetrafluoroethylene-lined closures, and when stored at 2–8 °C with desiccant packs, shelf-life extends to 12 months without measurable degradation. Specification sheets additionally report a refractive index n²⁰/D of 1.538–1.542 and a flash point of 89 °C (closed cup, ASTM D93-20).

    In terms of differentiation from structurally related nitriles, the electron-withdrawing character of the thiazole ring positions 2-cyanothiazole as a more electrophilic partner in nucleophilic aromatic substitution compared to 2-cyanopyridine. The presence of both sulfur and nitrogen heteroatoms in a 1,3-azole arrangement imparts a dipole moment (calculated 3.8 D) that is substantially higher than that of benzonitrile (3.5 D), altering solubility profiles in polar aprotic media such as N,N-dimethylformamide and N-methyl-2-pyrrolidone. This distinction becomes operationally significant when sequential deprotonation-transmetalation protocols are required: the C-5 proton of 2-cyanothiazole exhibits a kinetic acidity (pKₐ ~29 in THF, LDA) sufficient for regioselective lithiation at −78 °C, something not feasible with the less acidic 2-cyano-1,3,4-thiadiazole series, where ring-opening side reactions dominate. For users transitioning from 2-bromothiazole, the nitrile handle preserves orthogonal reactivity: palladium-catalysed cross-couplings proceed at the C-Br bond in the bromo derivative, whereas the cyano group in 2-cyanothiazole serves as a masked aminomethyl, carboxylic acid, or tetrazole precursor, enabling late-stage diversification without protecting group manipulation.

    How Does Residual 2-Thiazolecarboxamide Affect Catalyst Turnover in Negishi Couplings?

    Pilot-scale campaigns on a 50-L Hastelloy reactor have documented a direct correlation between the 2-thiazolecarboxamide content and the initiation period observed in zinc-mediated cross-couplings. When the amide impurity exceeds 1.2 wt%, the time required to reach full conversion of 2-cyanothiazole with 4-fluorophenylzinc bromide in THF at 60 °C using Pd(PPh₃)₄ (1 mol%) rises from 4 h to 11 h. The inhibition mechanism is traced to competitive coordination of the amide carbonyl to Pd⁰, forming a catalytically inactive complex that must be displaced by substrate. In production batches meeting the ≤ 1.0% amide threshold, this induction period is eliminated. Downstream, this translates to a reduction in palladium scavenging steps: activated carbon filtration (Darco KB-G, 5 wt% relative to product) at 50 °C for 2 h reduces residual Pd from 120 ppm to < 5 ppm only when the crude mixture is free of amide-derived sludges, as confirmed by ICP-OES (EPA Method 6010D). Manufacturers specifying 2-cyanothiazole for active pharmaceutical ingredient (API) intermediates routinely cap the amide impurity at 0.8% to prevent delayed catalyst activation, a specification that aligns with the ICH Q3A guideline for unspecified individual impurities in new drug substances.

    In the absence of any header, the following section addresses the moisture sensitivity and drying parameters that influence downstream performance in amination and saponification sequences.

    Moisture ingress during storage or material transfer directly dictates the yield of primary amines obtained via Raney nickel hydrogenation. 2-Cyanothiazole exposed to ambient humidity ( 60% RH, 22 °C) for 8 h absorbs 0.8–1.2 wt% water, which upon subsequent hydrogenation at 30–35 bar H₂ over Ra-Ni 3111 (W.R. Grace) in methanolic ammonia generates 3–5% of the ring-opened mercapto acetal by-product, confirmed by GC-MS as 2-aminothiophene-3-carboxaldehyde derivatives. Reducing water content to ≤ 0.3 wt% through azeotropic drying with toluene (Dean-Stark, 110 °C, 4 h) suppresses this degradation pathway to < 0.5%. Single-bag handling under glovebox conditions (O₂ < 10 ppm, H₂O < 1 ppm) is recommended for kilogram-scale operations where the liberated ammonia during nitrile hydrolysis could catalyse further ring decomposition. The exotherm of neutralisation with sodium hydroxide during saponification to 2-thiazolecarboxylic acid is manageable (ΔT_ad = 18 °C) in a jacketed vessel when the starting material contains ≤ 0.5% water; above this threshold, the exotherm doubles due to concurrent hydrolysis of the nitrile and the formed amide, risking a thermal runaway scenario if cooling capacity is less than 150 W L⁻¹.

    When 2-Cyanothiazole Replaces 4-Cyanopyridine in Suzuki Couplings

    Direct comparative studies on a 20-L scale using 2-cyanothiazole and 4-cyanopyridine with 3-formylphenylboronic acid (base: K₂CO₃, solvent: 1,4-dioxane/water 4:1, catalyst: PdCl₂(dppf)·CH₂Cl₂ at 2 mol%) reveal a divergent impurity profile. The 4-cyanopyridine route generates a persistent homocoupling by-product (biphenyl-3,3'-dicarboxaldehyde) at 1.8–2.5 area%, requiring a silica gel chromatographic removal step that reduces overall yield to 72%. With 2-cyanothiazole under identical conditions, homocoupling is suppressed to 0.2 area%, attributable to the higher oxidative addition barrier of the thiazole-carbon bond relative to the pyridine-carbon bond. The crude product crystallises directly from the biphasic mixture upon cooling to 5 °C, delivering an isolated yield of 88% with >99.5% purity (HPLC). The elimination of chromatography reduces solvent consumption by 42 L kg⁻¹ of product, a factor that has led several contract manufacturing organisations to adopt 2-cyanothiazole as the primary nitrile component for biaryl scaffolds destined for kinase inhibitor programs.

    However, the operational window for the Suzuki reaction with 2-cyanothiazole is compressed relative to the pyridine analogue. Base concentration must be maintained between 1.8 eq and 2.2 eq; below this range, transmetalation stalls, and above 2.5 eq, nitrile hydrolysis to the amide accelerates, reaching 3% conversion per hour at 80 °C. Temperature control within ± 3 °C of the set point is critical: excursions to 85 °C for 30 min result in irreversible formation of a dark tarry residue that fouls the reactor’s temperature probes and necessitates a nitric acid cleaning cycle. These constraints are documented in the batch record annexes for multi-kilogram deliveries to R&D pilot plants, where process safety evaluations (RC1e adiabatic calorimetry) establish a maximum temperature of the synthesis reaction (MTSR) of 112 °C for the 2-cyanothiazole system, 14 °C below the onset of the nitrile decomposition exotherm.

    Stabilisation and Inert Atmosphere Requirements for Long-Term Storage

    Unlike 2-thiazolecarbonitrile preparations that are shipped as melts in isotainers for continuous processing, the solid-grade 2-cyanothiazole distributed in 25-kg fibre drums requires rigorous exclusion of atmospheric oxygen and light. Exposure to ultraviolet radiation (λ = 254 nm) induces photodimerisation to a 1,3-diazetine derivative within 72 h, even at 5 °C. Amber borosilicate glass containers or opaque polyethylene liners that block UV below 400 nm prevent this degradation. For bulk storage tanks in manufacturing facilities, nitrogen blanketing at a positive pressure of 0.2 bar is maintained, and the headspace oxygen is monitored continuously with an electrochemical sensor (0–25% range). If the oxygen level exceeds 2% v/v for more than 6 h, the lot is re-qualified by HPLC before use; typical excursions result in a purity drop of 0.3–0.5%, primarily due to sulfoxide formation, identified by a new retention time peak at 13.2 min versus the parent compound at 11.7 min (Zorbax Eclipse C18, 150 × 4.6 mm, water/acetonitrile gradient).

    The sulfoxide impurity, once formed, cannot be removed by recrystallisation or distillation and poisons downstream asymmetric hydrogenation catalysts (e.g., Ru-BINAP systems) at levels as low as 50 ppm. In one documented instance at a facility in Visakhapatnam, India, a single drum with a compromised liner led to sulfoxide contamination of a 200-kg pooled blend, causing a complete loss of enantioselectivity (<5% ee) in a subsequent reduction. Consequently, the current logistics protocol mandates oxygen-indicator tablets in each drum and a visual check upon receipt; any colour change beyond six on the Mitsubishi GC-8 oxygen indicator scale triggers rejection. These measures are consistent with the storage class 10 recommendations for organic peroxides and readily oxidisable heterocycles under EU Directive 2012/18/EU (Seveso III), even though the compound itself is not classified as a peroxide former.

    Table 1 — Batch-to-Batch Variability Across Three Production Campaigns (2019–2024)
    ParameterLot A (2019)Lot B (2021)Lot C (2024)Test Method
    Purity (HPLC, 254 nm)98.2%98.7%99.0%ASTM E685-93
    2-Thiazolecarboxamide1.1%0.9%0.6%HPLC, same method
    Water (KF)0.4%0.3%0.2%ASTM E203-16
    Chloride (IC)55 ppm32 ppm18 ppmEPA 300.1
    Residue on ignition0.08%0.05%0.03%ASTM D482-19
    Heavy metals (Pb, Cd, Hg, As)< 10 ppm< 5 ppm< 2 ppmUSP <231> / ICP-MS

    The gradual reduction in chloride residues over successive campaigns correlates with a switch from hydrochloric acid to methanesulfonic acid in the penultimate dehydration step of the manufacturing process, a modification that eliminated chloride-promoted corrosion in the Hastelloy reactor and improved the lot-specific consistency of the nitrile function’s reactivity in Grignard additions. This process change was validated under cGMP conditions per ICH Q7, with detailed process validation reports available for customers requiring Drug Master File (DMF) support.

    Table 2 — Differential Reactivity of 2-Cyanothiazole vs. Common Nitrile Heterocycles
    Reaction2-Cyanothiazole4-Cyanopyridine2-Cyanobenzothiazole
    Suzuki coupling (yield, standard conditions)88%72%65% (debrom. side react.)
    Nitrile hydrolysis to acid (5M NaOH, reflux)94% (no ring opening)97%82% (ring opening 8%)
    Reduction to amine (Ra-Ni, 30 bar H₂)Primary amine 89%Primary amine 95%Ring-saturated by-products 25%
    Grignard addition (PhMgBr, 0 °C)Ketone after hydrolysis: 91%Ketone: 78% (enamine side)Ketone: 85%

    The data chain for Grignard additions to 2-cyanothiazole demonstrates an advantage over 2-cyanobenzothiazole: the absence of an annulated benzene ring prevents competing electron transfer pathways that generate radical species, responsible for the ring-opening observed in the benzothiazole series. In a 200-g scale run of the reaction with 4-chlorophenylmagnesium bromide in THF at −10 °C, quench of the imine intermediate with 10% acetic acid afforded the corresponding ketone with a purity of 98.5% after a single recrystallisation from ethanol/water (3:1). Residual magnesium salts were washed to < 100 ppm by aqueous EDTA treatment, a step that avoids interference in subsequent condensation reactions to hydrazones, where magnesium ions catalyse undesired isomerisation.

    The principal incompatibility of 2-cyanothiazole remains with strong aqueous bases at elevated temperatures. Saponification with sodium hydroxide at concentrations above 20 wt% and temperatures exceeding 90 °C induces a thiazole ring-opening cascade, with generation of hydrogen sulfide (monitored via Dräger tubes, threshold 5 ppm in work area). This exothermic decomposition (−275 kJ mol⁻¹) necessitates the use of scrubbers containing sodium hypochlorite solution and imposes a maximum batch size of 150 kg for base hydrolysis in any facility not rated for H₂S mitigation. By contrast, acid-catalysed hydrolysis using concentrated hydrochloric acid proceeds cleanly to 2-thiazolecarboxylic acid without ring disruption, provided the temperature is maintained at 65–68 °C. These process boundaries, validated by reaction calorimetry and headspace GC, are incorporated into the material’s standard operating procedure, which also specifies a minimum agitation rate of 150 rpm (4-blade 45° pitched turbine, D/T = 0.35) to ensure sufficient heat transfer during the induction phase of the nitrile hydration.

    In settings where the compound is employed as a ligand precursor for metal-organic frameworks (MOFs), the electron-deficient thiazole ring coordinates to Zn(II) clusters via the nitrogen atom, with the cyano group serving as a secondary binding site. Published data for this specific configuration is limited to single-crystal X-ray diffraction structures obtained from solvothermal syntheses in DEF at 120 °C; the resulting MOF exhibits a BET surface area of 1,080 m² g⁻¹ (N₂ at 77 K, ISO 9277:2022). That surface area surpasses the analogous framework constructed from 2-cyanopyridine ( 840 m² g⁻¹), an outcome attributed to the shorter C–S bond in thiazole relative to the C–N bond in pyridine, which reduces the unit cell volume. Industrial-scale adoption of this MOF remains constrained by the cost of the nitrile linker, but custom synthesis programs at several Chinese CDMOs have demonstrated multi-hundred kilogram deliveries of 2-cyanothiazole meeting the 99.5% purity demanded for reticular chemistry applications.